Alira Health

In Vitro Diagnostic Regulation Compliance

Navigate the IVDR Landscape With Confidence

Alira Health Meeting

The In Vitro Diagnostic Regulation (IVDR) introduces a stricter regulatory framework, reshaping market access for in vitro diagnostic (IVD) manufacturers in Europe. With 80% of IVDs now requiring notified body review, compliance has become more complex and time-sensitive.

Achieve IVDR compliance seamlessly. Whether launching a new device or adapting to the new regulations, our team of experts will guide you through every step—from classification and technical documentation to notified body engagement and market approval.

Let us help you bring your IVD to market with confidence. 

How We Help Clients Meet IVDR Requirements

Why Partner With Us for Your IVDR Compliance?

Ensure your IVDs, both new and existing, meet IVDR requirements on time. Recent transition extensions mean existing CE-marked devices must comply by May 2027, with some legacy devices extended up to 2029. For new products, compliance is critical from day one. Don’t risk delays—partner with our expert team for seamless compliance and a competitive edge:

Alira Health Meeting
 
 

Contact Us to Learn More About How We Can Support Your Needs

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.